Patents by Inventor Sebastien Papot

Sebastien Papot has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NEW THERAPEUTIC VECTORS AND PRODRUGS FOR TREATING CANCERS
    Publication number: 20220227741
    Abstract: The present invention relates to a compound having the following formula (I): as well as the corresponding prodrugs, pharmaceutical compositions comprising said compounds, in particular for treating cancer.
    Type: Application
    Filed: May 6, 2020
    Publication date: July 21, 2022
    Inventors: Sébastien PAPOT, Brigitte RENOUX, Rémi CHATRE
  • Conjugates and prodrugs for treating cancer and inflammatory diseases
    Patent number: 10293021
    Abstract: The present invention relates to the field of cancer and inflammatory diseases. More particularly, it aims to provide, for these purposes, novel conjugated forms of active ingredients belonging to the dolastatin family and having the formula as follows: It is also directed towards prodrug forms of these conjugates.
    Type: Grant
    Filed: February 6, 2015
    Date of Patent: May 21, 2019
    Assignees: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE DE POITIERS
    Inventors: Sebastien Papot, Isabelle Opalinski, Brigitte Renoux, Thibaut Legigan
  • CONJUGATES AND PRODRUGS FOR TREATING OF CANCER AND INFLAMMATORY DISEASES
    Publication number: 20170095525
    Abstract: The present invention relates to the field of cancer and inflammatory diseases. More particularly, it aims to provide, for these purposes, novel conjugated forms of active ingredients belonging to the dolastatin family and having the formula as follows: It is also directed towards prodrug forms of these conjugates.
    Type: Application
    Filed: February 6, 2015
    Publication date: April 6, 2017
    Inventors: Sebastien Papot, Isabelle OPALINSKI, Brigitte RENOUX, Thibaut LEGIGAN
  • Self-reactive arms and prodrugs comprising same
    Patent number: 9000135
    Abstract: The present invention relates to a compound of general formula (I): in which: X is OH, NH2, NHOH or RNH, where R may be a linear or branched, saturated or unsaturated, C1-C10 alkyl radical, Y is H, or an electron-withdrawing group, in particular selected from NO2, CF3 or a halogen, R1 and R2 are H or a linear or branched, saturated or unsaturated, C1-C10 alkyl radical, F is a reactive functional group that can be activated by click chemistry.
    Type: Grant
    Filed: May 18, 2011
    Date of Patent: April 7, 2015
    Assignees: Centre Nationale de Recherche Scientifique, Universite de Poitiers
    Inventors: Sebastien Papot, Mickael Thomas
  • NOVEL SELF-REACTIVE ARMS AND PRODRUGS COMPRISING SAME
    Publication number: 20130144045
    Abstract: The present invention relates to a compound of general formula (I): in which: X is OH, NH2, NHOH or RNH, where R may be a linear or branched, saturated or unsaturated, C1-C10 alkyl radical, Y is H, or an electron-withdrawing group, in particular selected from NO2, CF3 or a halogen, R1 and R2 are H or a linear or branched, saturated or unsaturated, C1-C10 alkyl radical, F is a reactive functional group that can be activated by click chemistry.
    Type: Application
    Filed: May 18, 2011
    Publication date: June 6, 2013
    Applicants: UNIVERSITE DE POITIERS, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Sebastien Papot, Mickael Thomas